Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.39) by 20.51 percent. The company reported quarterly sales of $10.18 million which beat the analyst consensus estimate of $8.60 million by 18.35 percent. This is a 72.51 percent increase over sales of $5.90 million the same period last year.
Sophia Genetics Q2 EPS $(0.31) Beats $(0.39) Estimate, Sales $10.18M Beat $8.60M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.39) by 20.51 percent. The company reported quarterly sales of $10.18 million which beat the
